Floatz logo

Asparaginase

Adult Acute Lymphoblastic Leukemia

Institute of Hematology & Blood Diseases Hospital, Chinaprotein_peptidePhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
89/ 100

Competitive context

65 Active assets in the Adult Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
Shanxi Bethune Hospital
Phase 4A
Dexasone
Shanxi Bethune Hospital
Phase 4BBB
Cytarabine
PETHEMA Foundation
Phase 4BBB
METHOTREXATE
PETHEMA Foundation
Phase 4BBB
Cyclophosphamide
The First Affiliated Hospital of Zhengzhou University
Phase 4BBB

View all 50 →

Same molecule, other indications

Asparaginase is also rated in:

childhood acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 3
72 / 100
View asset →
acute lymphoblastic leukemiaActive
BB
Indicative · Phase 4
71 / 100
View asset →
leukemiaDormant
BB
Indicative · Phase 3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →